相关实验视频
Updated: May 26, 2025
02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
5.2K
阿尔茨海默病与疼痛之间的共患病机制
Kaifang Yao1, Shenjun Wang1,2,3, Zhifang Xu1,2,3
1Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, P. R. China.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|February 25, 2025
概括
阿尔茨海默病患者经常因为认知问题而经历被忽视的疼痛. 这篇评论探讨了阿尔茨海默病和慢性疼痛之间的联系,重点关注神经炎症和神经递质.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 疼痛医学 医学 疼痛医学
背景情况:
- 临床研究表明,阿尔茨海默病 (AD) 和慢性疼痛 (CP) 之间存在强烈联系.
- 阿尔茨海默病患者,特别是晚期患者,由于认知和语言障碍,在疼痛评估和管理方面面临挑战.
- 导致AD和CP并发症的病理机制尚未完全理解.
研究的目的:
- 综合审查AD的临床特征和病理机制,有或没有CP.
- 检查神经炎症,免疫相互作用和神经递质动态在这种并发症中的作用.
- 要突出目前的疼痛评估和AD患者的管理策略.
主要方法:
- 对AD和疼痛的临床研究和研究的文献综述.
- 分析生物通路,包括神经退行,炎症和神经递质变化.
- 在AD的背景下检查疼痛评估工具和管理干预措施.
主要成果:
- 阿尔茨海默病和脑脊髓炎的并发症涉及相互连接的途径,如神经退行和炎症.
- 在阿尔茨海默病中,神经元和突触损伤会影响疼痛处理区域,可能会改变疼痛感知.
- 神经炎症是AD和CP的关键因素,增强的炎症反应会影响中枢神经系统和敏感化.
- 在AD和CP中共享的神经递质改变影响认知,情绪和疼痛感知.
结论:
- 了解AD和CP之间的复杂相互作用对于有效的患者护理至关重要.
- 针对神经炎症和神经递质失衡可能为AD相关的疼痛提供治疗策略.
- 本综述提供了一个框架,以改善疼痛管理和阿尔茨海默病患者的临床干预.
相关概念视频
01:25Analgesia and Pain Management
422
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
422
01:44Nociception
27.6K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.6K
01:26Alzheimer's Disease: Overview
422
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
422
01:20Pain
434
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
434
01:22Alzheimer's Disease: Treatment
147
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
147